Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03669575 · ClinicalTrials.gov registry record · NA
Omega 7 Oil and Inflammatory Biomarker Study
A NA study of Musculoskeletal Pain, sponsored by Bastyr University.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT03669575: Completed NA study of Musculoskeletal Pain, sponsored by Bastyr University.
NCT03669575 is a NA study of Musculoskeletal Pain that has completed, run by Bastyr University. The registered enrollment target is 56 participants, below the 154-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03669575, a NA study of Musculoskeletal Pain, has completed, sponsored by Bastyr University.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether the palmitoleic acid supplementation can reduce the serum inflammatory biomarkers and low quality of life scores due to musculoskeletal discomfort. The study design is a 2-arm placebo-controlled double blind crossover trial. The randomized sequence of a single crossover is divided into 1:1 and each supplementation is three weeks with no washout in between.
Primary Outcome
Quantification of the serum hsCRP level during active supplement
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT omega 7
Study Locations (1)
Washington
- Bastyr University Clinical Research Center - Kenmore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2019-10-01 |
| Phase | NA |
What the finished NCT03669575 record still lists
NCT03669575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 154-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Musculoskeletal Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03669575 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03669575 about?
NCT03669575 is a clinical study titled "Omega 7 Oil and Inflammatory Biomarker Study". The purpose of the study is to determine whether the palmitoleic acid supplementation can reduce the serum inflammatory biomarkers and low quality of life scores due to musculoskeletal discomfort. The study design is a 2-arm placebo-controlled double blind crossover trial. The randomized sequence of...
What is the current status of trial NCT03669575?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2017-09-01. Estimated completion is 2019-10-01.
What conditions does trial NCT03669575 study?
This clinical trial studies the following conditions: Musculoskeletal Pain.
What interventions are being tested in trial NCT03669575?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), omega 7 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03669575?
This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03669575 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Musculoskeletal Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03669575's enrollment target sits among peer trials
56 27th of 37 higher than 11 of 37 other Musculoskeletal Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Mechanisms and Modulation of Pain Modulatory Capacity
RECRUITING · NA
-
Equipping Patients Using Interventions for Pain and Depression
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI